INTELLIGENCE IN ACTION

Using Technology to Fight Opioid Fraud & Abuse—A Big Step in the Right Direction

August 26, 2016

In 2014, more than 28,000 American lives were cut short by opioid overdose. In fact, opioid overdose quadrupled from 2000 to 2014, and is now the nation’s number-one cause of preventable deathi.  But these potent prescription drugs—which include painkillers like morphine and oxycodone—can help to effectively manage chronic pain for millions of people when properly prescribed, administered and monitored.

Naturally, this puts prescribers in a uniquely challenging position. They must responsibly treat truly in-need patients with opioids, while taking steps to prevent abuse or to stop others from accessing the drugs. As Dr. James Holly, CEO of Southeast Texas Medical Associates (SETMA), said, “In Texas, prescribers are questioned when they prescribe controlled substances. They’re also questioned when they don’t. The regulatory burden falls squarely upon the prescriber, and that can adversely affect patients. So, in some cases, clinicians are less willing to prescribe controlled substances.”

The nation’s prescription drug abuse epidemic rages on, but as Surescripts’ 2015 National Progress Report highlights, Electronic Prescribing of Controlled Substances (EPCS) is emerging as a powerful and efficient tool for fighting it. By digitizing the process, prescribers have a valuable tool to prevent fraud and abuse (i.e., drug diversion, “doctor shopping,” etc.), auto-document their work for use during regulatory audits, and help ensure that the right patient gets the right medication without delay.

In 2015, EPCS became legal in all 50 states and Washington, D.C.  Since then, its use has increased dramatically. The number of prescribers enabled to use EPCS increased 359% in 2015, resulting in a more than 600% increase in e-prescription volume (or 12.8 million transactions) for these critical medications. New York helped drive nationwide adoption with its I-STOP mandate, requiring that all prescriptions for controlled substances be sent electronically, with a few exceptions. 

However, despite this exponential increase in EPCS adoption and its nationwide legality and availability, enablement among prescribers is still low when compared to pharmacies, with just under 6% of prescribers enabled for EPCS in 2015 as compared to 80% of pharmacies.

For prescribers using EPCS, it’s a game-changer. “With EPCS, every single step of the decision-making process as it relates to prescribing a controlled substance is documented automatically. In other words, now, we document it as we prescribe it. When a prescriber is audited, EPCS helps produce the required documentation in an instant, rather than having to manually track everything, which is virtually impossible due to the time and energy involved,” Dr. Holly said.

Texas, where Dr. Holly practices, is currently ranked seventh in the country in prescriber and pharmacy enablement, as well EPCS transaction volume. Click here for more information on state-level EPCS enablement data, including the complete ranking for each state. Below, you can see what types of providers are using EPCS the most. Family practitioners transmit about one-third (32%) of all e-prescriptions for controlled substances.

EPCS Transcriptions by Provider Specialty

Using the power of Surescripts’ nationwide healthcare information network, prescribers and pharmacies now have access to the electronic tools they need to help fight fraud and abuse of controlled substances while effectively serving the patients who need them. As Surescripts’ 2015 National Progress Report shows, while there’s still a long way to go to 100% EPCS adoption, the growth in enablement over the past year alone indicates a big step in the right direction.

1.i CDC/NCHS, National Vital Statistics System, Mortality: http://www.cdc.gov/drugoverdose/data/statedeaths.html

Related Articles

March 31, 2020

Five Questions: Ken Whittemore Talks Past, Present & Future of E-Prescribing Controlled Substances

In the early 2000s, as the nation moved towards e-prescribing, Ken Whittemore Jr. was one of the key drivers and proponents of this new technology. By 2007, as a result of the efforts of Surescripts and other stakeholders, e-prescribing had become legal in all 50 states. Three years later, the regulatory climate was ready for the next leap in e-prescribing: in March 2010, the U.S. Drug Enforcement Administration (DEA) issued an Interim Final Rule (IFR) allowing for the electronic prescribing of controlled substances (EPCS) across the nation.  Read more...
February 05, 2020

How a Rural Health System is Transforming Lives in the Face of Addiction

The tragedy of the opioid epidemic is inescapable. According to the latest provisional numbers from the Centers for Disease Control and Prevention (CDC), opioids were involved in more than 47,000 overdose deaths in 2018--that’s more than 5 people every hour. American life expectancy is declining for the first time in more than 50 years, attributed to the dramatic increase in drug overdose deaths. This tragedy is recounted in headlines and obituaries and statistics, but the dashed dreams and potential of those lost is immeasurable.

Read more...
January 13, 2020

Changing the Script on the Opioid Crisis

In a recent video interview, Marriott discusses how he and his team are helping the people of Connecticut get the care they need, while also battling an opioid epidemic that has devastated communities across the state. It’s clearly not just a job for Marriot Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX